Loading...
XSHE
000623
Market cap3.14bUSD
Jul 09, Last price  
17.83CNY
1D
0.73%
1Q
-2.25%
Jan 2017
-25.21%
Name

Jilin Aodong Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:000623 chart
P/E
8.90
P/S
9.13
EPS
2.00
Div Yield, %
2.80%
Shrs. gr., 5y
-2.45%
Rev. gr., 5y
0.73%
Revenues
2.34b
-10.55%
770,228,862845,146,602927,821,7911,025,515,4981,113,327,7671,145,230,6671,445,463,1691,956,861,1702,240,099,3432,334,760,8362,736,697,0772,976,771,6433,324,078,2653,088,379,5902,251,650,9492,303,763,7632,868,211,4643,449,123,3012,610,575,1032,335,191,262
Net income
2.40b
+54.39%
487,203,9151,992,259,763861,607,7961,366,488,9811,237,656,4651,982,049,203646,417,2101,058,789,4091,410,692,5452,593,589,3201,666,491,3651,863,471,364935,187,8941,403,640,3141,708,876,0561,780,500,3731,780,801,3531,459,879,6841,551,393,0712,395,240,138
CFO
272m
+357.70%
187,992,627384,693,029235,027,833213,027,240174,221,772108,303,405272,401,616201,217,819288,827,750388,032,364333,812,958256,485,969347,635,221379,456,901390,408,759324,846,060423,856,81568,060,61359,483,507272,258,821
Dividend
Oct 22, 20250.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
IPO date
Oct 28, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT